Hirokuni Takano

15PUBLICATIONS
114CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematological tumoursTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 17, 2026
Changes and clinical impact of HER3 and ERBB3 expression in primary and recurrent ovarian cancer.

|Jul 25, 2026
A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101).

|Jul 25, 2026
Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis.

|Jul 23, 2026
Ureteral Metastasis From Endometrial Carcinoma Mimicking Upper Tract Urothelial Carcinoma.

|Nov 07, 2025
Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients.

Satoshi Yanagida, Yuichi Shoburu, Takako Kiyokawa

|Jul 01, 2025
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.

Shin Nishio, Tadaaki Nishikawa, Masahiko Mori

Pageof 3

Frequent Collaborators

10 joint publications

Aikou Okamoto

6 joint publications

Motoaki Saito

5 joint publications

Hiroshi Tanabe

5 joint publications

Kyosuke Yamada